Old Web
English
Sign In
Acemap
>
authorDetail
>
Sathyajith E. Kumarasinghe
Sathyajith E. Kumarasinghe
Merck & Co.
Kinase
Chemistry
Potency
Tricyclic
In vivo
2
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The discovery of reverse tricyclic pyridone JAK2 inhibitors. Part 2: Lead optimization
2014
Bioorganic & Medicinal Chemistry Letters
Tony Siu
Sathyajith E. Kumarasinghe
Michael D. Altman
Matthew H. Katcher
Alan B. Northrup
Catherine White
Craig Rosenstein
Anjili Mathur
Lin Xu
Grace Chan
Eric Bachman
Melaney Bouthillette
Christopher J. Dinsmore
C. Gary Marshall
Jonathan R. Young
Show All
Source
Cite
Save
Citations (3)
Inhibiteurs de pyrazolo[3,4-b]pyridin-4-one kinase
2010
Tony Siu
Christopher J. Dinsmore
Sathyajith E. Kumarasinghe
Show All
Source
Cite
Save
Citations (0)
1